| NCT04215146 | A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study | ACTIVE_NOT_RECRUITING | PHASE2 | 2020-06-10 | 2025-06 | 2022-08-01 |
| NCT04102618 | A Window-of-opportunity Study of Pelareorep in Early Breast Cancer | TERMINATED | EARLY_PHASE1 | 2019-03-29 | 2022-04-20 | 2022-04-20 |
| NCT02723838 | Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder | WITHDRAWN | PHASE1 | 2017-02-28 | 2018-02-28 | 2017-09-30 |
| NCT02620423 | Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma | COMPLETED | PHASE1 | 2015-12 | 2018-08 | 2018-03 |
| NCT01274624 | Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer | COMPLETED | PHASE1 | 2010-12 | 2018-11 | 2018-02 |
| NCT01166542 | Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | COMPLETED | PHASE3 | 2010-06 | 2014-05 | 2012-04 |
| NCT00998192 | A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | COMPLETED | PHASE2 | 2009-10 | 2015-08 | 2013-09 |
| NCT00998322 | A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | COMPLETED | PHASE2 | 2009-10 | 2015-02 | 2013-12 |
| NCT00984464 | Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | COMPLETED | PHASE2 | 2009-09 | 2014-10 | 2014-02 |
| NCT00861627 | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation | COMPLETED | PHASE2 | 2009-03 | 2015-11 | 2015-09 |
| NCT00753038 | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma | COMPLETED | PHASE2 | 2008-08 | 2013-05 | 2011-07 |
| NCT00503295 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung | COMPLETED | PHASE2 | 2007-06 | 2011-04 | 2011-02 |
| NCT00528684 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas | COMPLETED | PHASE1 | 2006-07 | 2010-06 | 2010-04 |